• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Khalil, M. (2021). SERUM LEVELS OF SOLUBLE FMS –LIKE TYROSINE KINASE -1 IN PRE-ECLAMPTIC AND ECLAMPTIC CASES AND ITS CORRELATION TO FETOMATERNAL OUTCOME. ALEXMED ePosters, 3(2), 9-10. doi: 10.21608/alexpo.2021.63856.1124
Merihan Mahmoud Khalil. "SERUM LEVELS OF SOLUBLE FMS –LIKE TYROSINE KINASE -1 IN PRE-ECLAMPTIC AND ECLAMPTIC CASES AND ITS CORRELATION TO FETOMATERNAL OUTCOME". ALEXMED ePosters, 3, 2, 2021, 9-10. doi: 10.21608/alexpo.2021.63856.1124
Khalil, M. (2021). 'SERUM LEVELS OF SOLUBLE FMS –LIKE TYROSINE KINASE -1 IN PRE-ECLAMPTIC AND ECLAMPTIC CASES AND ITS CORRELATION TO FETOMATERNAL OUTCOME', ALEXMED ePosters, 3(2), pp. 9-10. doi: 10.21608/alexpo.2021.63856.1124
Khalil, M. SERUM LEVELS OF SOLUBLE FMS –LIKE TYROSINE KINASE -1 IN PRE-ECLAMPTIC AND ECLAMPTIC CASES AND ITS CORRELATION TO FETOMATERNAL OUTCOME. ALEXMED ePosters, 2021; 3(2): 9-10. doi: 10.21608/alexpo.2021.63856.1124

SERUM LEVELS OF SOLUBLE FMS –LIKE TYROSINE KINASE -1 IN PRE-ECLAMPTIC AND ECLAMPTIC CASES AND ITS CORRELATION TO FETOMATERNAL OUTCOME

Article 83, Volume 3, Issue 2, June 2021, Page 9-10  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.63856.1124
View on SCiNiTO View on SCiNiTO
Author
Merihan Mahmoud Khalil email
Department of Obstetrics and Gynecology, Shatby Maternity Hospital, Faculty of Medicine, Alexandria University, Egypt
Abstract
Preeclampsia is a multisystem progressive disorder characterized by the new onset of hypertension and proteinuria or the new onset of hypertension and significant end-organ dysfunction with or without proteinuria after 20 weeks of gestation or postpartum in previously normotensive women. It is develops due to placental and maternal vascular dysfunction and disappears after delivery gradually by time. The incidence is estimated to be between 3 and 10% of all pregnancies.
Maternal endothelial dysfunction which leads to pre-eclamptic signs and symptoms is induced by high levels of the antiangiogenic factor sFLT1, which is produced in the placenta and released into the maternal circulation. sFLT1 is a soluble splice variant of the membrane-bound receptor VEGFR1 that binds to the proangiogenic proteins VEGF and placental growth factor (PlGF); therefore, sFLT1 acts as a ligand trap and antagonizes ligand-mediated angiogenic signalling via the cell surface receptors.
Aim of the work
The aim of this work was to evaluate serum levels of soluble fms-like tyrosine kinase-1 (sFlt-1) in cases of severe preeclampsia and eclamptic fits,and to correlate serum levels of soluble fms-like tyrosine kinase-1 (sFlt-1) in these cases to outcome of fetus and mother and incidence of complication.
Keywords
antiangiogenic factor sFLT1; significantly increased in severe preeclampsia; cutoff point to predict eclamptic fits >11588.74pg/dl
Supplementary Files
download 0009 Presentation12.pdf
Statistics
Article View: 196
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.